EP1515728A2 - USE OF ORALLY-AVAILABLE PROSTACYCLIN DERIVATIVES FOR THE PRODUCTION OF A MEDICAMENT FOR THE TREATMENT OF DISEASE STATES ASSOCIATED WITH BONE MARROW OEDEMA